FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Suzanne Hill

Research Profile

Concepts & Ideas

Activities & Behaviors

Geographic Areas

Organizations

Chemicals & Drugs

Procedures

Drug Utilization Review

Anatomy

Bacterial Capsules

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Jane Robertson; Gilles Forte; Jean-Marie Trapsida; Suzanne Hill
What essential medicines for children are on the shelf?
David Henry; Evan Doran; Ian Kerridge; Suzanne Hill; Paul M McNeill; Richard Day
Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.
Regina Brinsmead; Suzanne Hill; DAMIAN WALKER
Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Suzanne Hill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2009: Jane Robertson; Gilles Forte; Jean-Marie Trapsida; Suzanne Hill
What essential medicines for children are on the shelf?
Bulletin of the World Health Organization 2009;87(3):231-7.
2005: David Henry; Evan Doran; Ian Kerridge; Suzanne Hill; Paul M McNeill; Richard Day
Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.
Archives of internal medicine 2005;165(21):2493-6.
2004: Regina Brinsmead; Suzanne Hill; DAMIAN WALKER
Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.
The Pediatric infectious disease journal 2004;23(1):32-7.
2003: R Brinsmead; Suzanne Hill
Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?
Journal of clinical pharmacy and therapeutics 2003;28(4):339-46.
2003: D Newby; Suzanne Hill
Use of pharmacoeconomics in prescribing research. Part 2: cost-minimization analysis--when are two therapies equal?
Journal of clinical pharmacy and therapeutics 2003;28(2):145-50.
2003: Jane Robertson; D Lang; Suzanne Hill
Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
Journal of clinical pharmacy and therapeutics 2003;28(1):73-9.
2003: Suzanne Hill; Nick Freemantle
A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?
PharmacoEconomics 2003;21(11):761-7.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.